Latest Breaking News On - Session display date - Page 1 : comparemela.com

Allogene Therapeutics Announces Three Poster Presentations from its Next Generation AlloCAR T™ Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Allogene Therapeutics Announces Three Poster Presentations from its Next Generation AlloCAR T™ Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

South san franciscoUnited statesSan diegoAllogene alloElvin lauronJoanne liChristine cassianoZachary robertsCorporate affairs brand strategyTechnology to engineerPreclinical developmentAllogene therapeutics incResearch developmentTechnology to engineer allogeneic cellsSociety for immunotherapy of cancerTherapeutics announces three poster presentations

Allogene Therapeutics Announces Three Poster Presentations from its Next Generation AlloCAR T Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

27.09.2023 - Spotlight on Novel, Targeted Technologies to Enhance Engraftment, Expansion and Persistence of AlloCAR T Cells Demonstration of Dagger Technology to Engineer CAR T cells to Selectively Eliminate CD70 Positive, Allo-Reactive Host Immune . Seite 1

San diegoUnited statesZachary robertsElvin lauronResearch developmentAllogene therapeutics incDemonstration of dagger technology to engineerSociety for immunotherapy of cancerTargeted technologiesEnhance engraftmentDagger technologySelectively eliminateAllo reactive host immune cellsCloak technologyEngineer allogeneic cellsHost immune system

Allogene Therapeutics Announces Three Poster Presentations from its Next Generation AlloCAR T™ Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Allogene Therapeutics Announces Three Poster Presentations from its Next Generation AlloCAR T™ Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesSouth san franciscoElvin lauronChristine cassianoZachary robertsJoanne liAllogene alloPreclinical developmentSociety for immunotherapy of cancerTechnology to engineer allogeneic cellsTechnology to engineerResearch developmentCorporate affairs brand strategyAllogene therapeutics incTargeted technologies

Triumvira Immunologics Highlights Positive Phase 1 Clinical Data on TAC01-HER2 in Solid Tumors at ASCO 2023 Annual Meeting

/PRNewswire/ Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the.

United statesSouth san franciscoDeyaa adibPrnewswire triumvira immunologicsDavid schullBenjaminl schlechterBenjamin schlechterIgnacio guerrero rosTriumvira immunologicsDana farber cancer instituteHarvard medical schoolAmerican societyTriumvira immunologics incSociety of clinical oncologyAnnual meetingSenior physician

Tvardi Therapeutics Announces Presentation of Data from the Phase 1 Trial of TTI-101, a STAT3 inhibitor, in Advanced Solid Tumors at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

HOUSTON (BUSINESS WIRE) May 25, 2023

United statesImran alibhaiSara manningApostoliam tsimberidouAmerican society of clinical oncologyTvardi therapeutics incAmerican societyClinical oncologyPoster discussion sessionTargeted agentsSession display dateBoard numberDiscussion session dateTvardi investorBusiness wire